Gene · 60489
Papers3,812
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,812
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A scalable ultra-long-acting tenofovir phosphonate prodrug sustains HBV suppression. | Sci Adv | 2025 | 40749058 | PubTator, text mining | PubMed |
| Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions. | Open Forum Infect Dis | 2025 | 40735332 | PubTator, text mining | PubMed |
| A single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron. | Nat Commun | 2025 | 40730568 | PubTator, text mining | PubMed |
| Mechanisms of Immune Evasion in HIV-1: The Role of Virus-Host Protein Interactions. | Curr Issues Mol Biol | 2025 | 40699766 | PubTator, text mining | PubMed |
| cytoKernel: robust kernel embeddings for assessing differential expression of single-cell data. | Bioinformatics | 2025 | 40658464 | PubTator, text mining | PubMed |
| DNA hairpin base-flipping dynamics drives APOBEC3A recognition and selectivity. | Phys Chem Chem Phys | 2025 | 40371934 | PubTator, text mining | PubMed |
| Discovery of a novel polymyxin adjuvant against multidrug-resistant gram-negative bacteria through oxidative stress modulation. | Acta Pharm Sin B | 2025 | 40370545 | PubTator, text mining | PubMed |
| HIV-1 cell-to-cell infection of macrophages escapes type I interferon and host restriction factors, and is resistant to antiretroviral drugs. | PLoS Pathog | 2025 | 40294108 | PubTator, text mining | PubMed |
| Design and Characterization of Inhibitors of Cell-Mediated Degradation of APOBEC3G That Decrease HIV-1 Infectivity. | Viruses | 2025 | 40284957 | PubTator, text mining | PubMed |
| Purification of enzymatically active APOBEC proteins from an insect cell expression system. | Methods Enzymol | 2025 | 40250960 | PubTator, text mining | PubMed |
| APOBEC3G Antagonism by Vif, or When Structure Meets Biological and Evolutionary Studies. | Annu Rev Virol | 2025 | 40198850 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Roles of APOBEC3 Gene Family in Clear Cell Renal Cell Carcinoma. | Arch Esp Urol | 2025 | 40191862 | PubTator, text mining | PubMed |
| Next generation APOBEC3 inhibitors: optimally designed for potency and nuclease stability. | Nucleic Acids Res | 2025 | 40156866 | PubTator, text mining | PubMed |
| Coevolution of Lentiviral Vif with Host A3F and A3G: Insights from Computational Modelling and Ancestral Sequence Reconstruction. | Viruses | 2025 | 40143321 | PubTator, text mining | PubMed |
| RNA-binding protein expression based machine learning model predicts metastasis and treatment outcome of testicular cancer. | Genes Genomics | 2025 | 40138122 | PubTator, text mining | PubMed |
| HIV-1 Vif disrupts phosphatase feedback regulation at the kinetochore, leading to a pronounced pseudo-metaphase arrest. | Elife | 2025 | 40080415 | PubTator, text mining | PubMed |
| Finding Potential Drug Targets for Pre-Eclampsia Using Mendelian Randomisation and Colocalisation Analysis. | Am J Reprod Immunol | 2025 | 40028697 | PubTator, text mining | PubMed |
| Single-cell delineation of strain-specific HIV-1 Vif activities using dual reporter sensor cells and live cell imaging. | J Virol | 2025 | 39998123 | PubTator, text mining | PubMed |
| Hypermut 3: identifying specific mutational patterns in a defined nucleotide context that allows multistate characters. | Bioinform Adv | 2025 | 39981109 | PubTator, text mining | PubMed |
| Exploration of common molecular mechanisms of psoriatic arthritis and aging based on integrated bioinformatics and single-cell RNA-seq analysis. | Biochim Biophys Acta Mol Basis Dis | 2025 | 39965531 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/60489/papers?page=4